Questions around this news
What is epigenetics?
Epigenetics studies changes in how genes are regulated without changing the underlying DNA sequence. These changes can affect whether particular genes are active and how strongly they are expressed. Factors such as behavior and environmental conditions can influence some epigenetic patterns, though effects vary and do not mean that every change is permanent.
How does epigenetics differ from genetics?
Genetics concerns inherited DNA variations and the sequence of genetic code. Epigenetics concerns mechanisms that affect how genes are used without altering that sequence. The release says inherited factors contribute to cardiovascular risk, while arguing that DNA sequence alone gives an incomplete picture of risk.
What does the release say about Cardio Diagnostics’ cardiovascular testing focus?
The release describes Cardio Diagnostics Holdings as a medical technology company whose cardiovascular testing platform is built around epigenetics. It says the company has made epigenetic science central to its diagnostic approach, but the supplied text does not explain how a specific test works or identify particular test results.
Can lifestyle and environment affect epigenetic patterns?
Some lifestyle and environmental influences can affect epigenetic mechanisms, which regulate gene activity without changing DNA sequence. This is one reason epigenetic information may reflect more than inherited DNA alone. However, the presence of an epigenetic change does not by itself establish a person’s health status or explain the cause of a disease.
- Cardio Diagnostics has positioned the science of epigenetics at the center of its diagnostic platform.
- Looking at an individual person’s epigenetics can provide invaluable insight into the impact of their lifestyle, behavior, and environment.
- Epigenetics does more than pinpoint a problem, says CEO; it also provides some level of solution.
When most people think about their risk for heart disease, they think about family history. Did a parent or grandparent have a heart attack? Is heart disease “in their genes”? It’s an understandable assumption, and genetics does play a role in cardiovascular risk. But a growing body of research suggests that DNA sequence alone tells only part of the story, and increasingly, scientists believe it may be the smaller part. The rest of the story is largely written in epigenetics, a field of biology that examines how genes are switched on or off, turned up or down, without any change to the underlying DNA code itself. Cardio Diagnostics Holdings (NASDAQ: CDIO), a medical technology company built around epigenetics-based cardiovascular testing, has positioned this science at the center of its diagnostic platform.
Understanding the basic concept of epigenetics is key. Think of DNA as a massive instruction manual containing every gene a person could ever use. That manual does not change much over a lifetime. What does change is which pages get read, how often and how loudly. Epigenetics is essentially the…
NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO
Corporate Communications
IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
[email protected]
At a glance
- Company
- Cardio Diagnostics Holdings
- Ticker
- NASDAQ: CDIO
Products and programs
SEC filings
Earlier from Cardio Diagnostics Holdings
- Cardio Diagnostics Holdings (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection
- Cardio Diagnostics Holdings (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians
- Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets a $393B Heart Disease Problem with Epigenetics and AI
- Cardio Diagnostics Holdings (NASDAQ: CDIO) Offers Broad Suite of AI-Powered Solutions for Cardiovascular Disease Prevention
- Cardio Diagnostics Holdings (NASDAQ: CDIO) Advancing Early Detection, Tackling Heart Disease Through AI and Biomarker Insights
